Study of the Best Timing for Plerixafor in Autologous Hematopoietic Stem Cell Collection

NCT01042717 · clinicaltrials.gov ↗

NA

Phase

UNKNOWN

Status

10

Enrollment

INDIV

Sponsor class

Conditions

Multiple Myeloma
Non-Hodgkins Lymphoma

Interventions

DRUG: Plerixafor

Sponsor

Shi, Patricia, M.D.

Collaborators

[object Object]